Darci J. Phillips
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Darci J. Phillips has a total of 180 co-authors. Here are the top co-authors by number of shared publications:
- Garry P. Nolan
Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA
47 shared publications - Aaron M. Newman
Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA.
40 shared publications - Jeanne Shen
Department of Pathology, Stanford School of Medicine, Stanford, USA
40 shared publications - John W. Hickey
Duke University
40 shared publications - Matt van de Rijn
Department of Pathology, Stanford University, Stanford, California
40 shared publications - Bogdan Luca
Department of Medicine, Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, California. 2
39 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Spatially Segregated Macrophage Populations Predict Distinct Outcomes in Colon Cancer
This Figure illustrates spatial segregation of IL4I1+ vs FOLR2+ macrophages in BC and CRC tumor metastasis to the LN, and across eight different tumor types.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Spatially Segregated Macrophage Populations Predict Distinct Outcomes in Colon Cancer
This Figure illustrates spatial segregation of IL4I1+ vs FOLR2+ macrophages in BC and CRC tumor metastasis to the LN, and across eight different tumor types.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from Spatially Segregated Macrophage Populations Predict Distinct Outcomes in Colon Cancer
This Figure shows protein marker expression across different cell types detected in CODEX experiment, macrophage distance to the closest tumor cell, macrophage distribution across different tissue niches, and tissue niche distribution across different anatomical locations.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Spatially Segregated Macrophage Populations Predict Distinct Outcomes in Colon Cancer
This Figure shows protein marker expression across different cell types detected in CODEX experiment, macrophage distance to the closest tumor cell, macrophage distribution across different tissue niches, and tissue niche distribution across different anatomical locations.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S9 from Spatially Segregated Macrophage Populations Predict Distinct Outcomes in Colon Cancer
This Figure is a visual summary of this work’s findings and shows the spatial distribution of distinct macrophage subsets in the tumor microenvironment and the clinical significance of IL4I1+ and SPP1+ macrophages in breast and colon tumors.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S9 from Spatially Segregated Macrophage Populations Predict Distinct Outcomes in Colon Cancer
This Figure is a visual summary of this work’s findings and shows the spatial distribution of distinct macrophage subsets in the tumor microenvironment and the clinical significance of IL4I1+ and SPP1+ macrophages in breast and colon tumors.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S7 from Spatially Segregated Macrophage Populations Predict Distinct Outcomes in Colon Cancer
Thus Figure shows spatial enrichment of NLRP3+ macrophages with neutrophils in Crohn’s Disease, and immunostimulatory and immunosuppressive protein marker expression in NLRP3+ vs SPP1+ macrophages.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S7 from Spatially Segregated Macrophage Populations Predict Distinct Outcomes in Colon Cancer
Thus Figure shows spatial enrichment of NLRP3+ macrophages with neutrophils in Crohn’s Disease, and immunostimulatory and immunosuppressive protein marker expression in NLRP3+ vs SPP1+ macrophages.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from Spatially Segregated Macrophage Populations Predict Distinct Outcomes in Colon Cancer
Thus Figure shows CD274 gene scRNAseq expression across different cell types and datasets.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from Spatially Segregated Macrophage Populations Predict Distinct Outcomes in Colon Cancer
Thus Figure shows CD274 gene scRNAseq expression across different cell types and datasets.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S8 from Spatially Segregated Macrophage Populations Predict Distinct Outcomes in Colon Cancer
This Figure shows Kaplan-Meier plots of CRC patient samples stratified by IL4I1+ macrophage counts.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S8 from Spatially Segregated Macrophage Populations Predict Distinct Outcomes in Colon Cancer
This Figure shows Kaplan-Meier plots of CRC patient samples stratified by IL4I1+ macrophage counts.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S1 from Spatially Segregated Macrophage Populations Predict Distinct Outcomes in Colon Cancer
Supplementary Table 1. List of IHC antibodies
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Spatially Segregated Macrophage Populations Predict Distinct Outcomes in Colon Cancer
Supplementary Table 1. List of IHC antibodies
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S3 from Spatially Segregated Macrophage Populations Predict Distinct Outcomes in Colon Cancer
Supplementary Table 3. CODEX imiging cycles record
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Spatially Segregated Macrophage Populations Predict Distinct Outcomes in Colon Cancer
Supplementary Table 3. CODEX imiging cycles record
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from Spatially Segregated Macrophage Populations Predict Distinct Outcomes in Colon Cancer
Thus Figure illustrates how macrophage subsets detected using scRNAseq, 4-color IF, and CODEX correspond to each other and shows representative examples of protein marker expression across macrophage niches.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Spatially Segregated Macrophage Populations Predict Distinct Outcomes in Colon Cancer
Thus Figure illustrates how macrophage subsets detected using scRNAseq, 4-color IF, and CODEX correspond to each other and shows representative examples of protein marker expression across macrophage niches.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from Spatially Segregated Macrophage Populations Predict Distinct Outcomes in Colon Cancer
This Figure shows the spatial interaction of FOLR2+ macrophages with Plasma Cells in normal colon lamina propria, normal breast, normal lymph node, and breast cancer adjacent normal tissue. It also illustrates ligand-receptor interactions predicted to occur between FOLR2+ macrophages and Plasma Cells.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from Spatially Segregated Macrophage Populations Predict Distinct Outcomes in Colon Cancer
This Figure shows the spatial interaction of FOLR2+ macrophages with Plasma Cells in normal colon lamina propria, normal breast, normal lymph node, and breast cancer adjacent normal tissue. It also illustrates ligand-receptor interactions predicted to occur between FOLR2+ macrophages and Plasma Cells.